More Days of THC Dosing Did Not Produce a Steady Increase in Mouse Tolerance

A mouse study found that measured THC tolerance increased early in repeated dosing but was smaller at a later treatment point. The relationship between exposure duration and the measured potency shift was therefore not a simple steady climb.

The same repeated regimen was sampled at different times

Mice received subcutaneous THC twice daily. Testing 24 hours after the last injection assessed antinociception and suppression of spontaneous activity. Tolerance appeared after three injections, increased after seven and was smaller after thirteen injections on both measures. Those observations describe the reported dose-response results; they do not by themselves identify why the pattern changed.

The size of the change depended on the outcome

The activity measure showed larger early potency shifts than antinociception. Consequently, a single numerical tolerance factor would not accurately describe the whole experiment. Potency shifts also differ from proving that an effect became impossible at every dose.

Recovery had its own endpoint-specific pattern

A separate group was tested at intervals after a longer dosing regimen ended. Activity tolerance was no longer detected at a point when antinociceptive tolerance remained. The study therefore examined both induction and maintenance without demonstrating one common mechanism or timeline.

The useful conclusion is that duration alone did not predict tolerance monotonically under these conditions. This does not establish a recommended human abstinence period or indicate that continued cannabis use reliably reduces tolerance. Species, injected dosing and the selected behavioral tests limit that translation.

Related: interpreting cannabis tolerance claims.

Research cited

Bass CE; Martin BR. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice. Drug and alcohol dependence (2000). doi:10.1016/s0376-8716(99)00150-7. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us